# Straumann Group acquires 30% stake in botiss medical AG

The Straumann Group acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum, to expand distribution of botiss products and secure access to its technology.

- Type: Acquisition
- Announced: 2018-07-04
- Where: Berlin, Germany
- Status: announced
- Products: biomaterials for oral surgery
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Straumann Holding AG](https://endata.com/companies/20348.md) (acquirer)
- [botiss medical AG](https://endata.com/companies/32934.md) (target)

## Sources

- [botiss.com](https://botiss.com/straumann-group-acquires-30-stake-in-botiss/), 2018-07-04: "The Straumann Group has acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.